Good day ladies, and gentlemen, and welcome to the Fourth Quarter 2007 Celanese Corporation Earnings Conference Call. My name is Fab and I will be your coordinator for today. At this time, all participants are in listen-only mode. We will conduct a question-and-answer session towards the end of this conference. [Operator Instructions]. As a reminder, this conference is being recorded for replay purposes. I would now like to turn the presentation over to your host for today's call Mr. Mark Oberle, Vice President of Investor Relations and Public affairs. Please proceed.

Thank you and welcome to the Celanese Corporation fourth quarter 2007 financial results conference call. My name is Mark Oberle, Vice President of Investor Relations, and Public Affairs. On the call today are David Weidman, Chairman and Chief Executive Officer; and Steven Sterin, Senior Vice President, and Chief Financial Officer. The Celanese Corporation press release was distributed via Business Wire this morning and is posted on our website at celanese.com During this call management may make forward-looking statements concerning, for example, Celanese Corporation's future objectives, and results, which will be made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations, and are subject to uncertainty, and changes in circumstances. Actual results may differ materially from these expectations due to changes in economic, business, competitive, market, political, and regulatory factors. More detailed information about these factors is contained in the earnings release, and in Celanese Corporation's filings with the Securities and Exchange Commission. Celanese Corporation undertakes no obligation to update publicly, or revise any forward-looking statements. Celanese Corporation's fourth quarter 2007 earnings release references the performance measures, operating EBITDA, affiliate EBITDA, adjusted earnings per share, net debt, and adjusted free cash flow as non-U.S. GAAP measures. For the most directly comparable financial measures presented in accordance with U.S. GAAP, and our financial statements, and for a reconciliation of our non-U.S. GAAP measures to U.S. GAAP figures, please see the company's schedules to our earnings release, which will also be posted on our website. This morning Dave Weidman will review the performance of the company, and Steven Sterin will provide an overview of the business results for each segment, and the financials. We will have a question-and-answer period following the prepared remarks. Now I would like to turn the call over to Dave Weidman. Dave.

Mark, thank you and welcome everyone to today's call. It's my pleasure to provide you with highlights of our record-setting performance in 2007, and share our expectations for 2008. We concluded 2007's record year with a very strong fourth quarter. Sales in the quarter were $1.8 billion, up 23% from the same period last year. Adjusted EPS was $0.93 per share, and our operating EBITDA was $349 million, both records for the quarter. Our full year sales were $6.4 billion, adjusted EPS was $3.42 per share, and operating EBITDA was $1.325 million. Our fourth quarter performance came in somewhat stronger than expectations, we shared during Investor Day, in December, primarily due to stronger demand, better pricing particularly in Acetyl Intermediates, and Industrial Specialties, and lower cost across the company. Though we are pleased with our 2007 performance, the future looks even better. Over the last several years, our strategy, and culture of execution has delivered increasingly improved results. Our integrated businesses are delivering, and will continue to deliver high quality earnings. This past year's stellar results were achieved in an environment pressured by volatile raw materials, and energy costs, operational disruptions throughout the industry including our own company, and sluggish economic trends in a few specific areas. But Celanese is resilient, because of the global balance, and end market diversity of our businesses, and our strong business models, we delivered great earnings growth, and strong cash generation in 2007. However as good as last year's results were 2008 and beyond look even better. Contributions from Celanese earnings growth plan, a program, which was initially outlined during our 2006 Investor Day lifted 2007 earnings by about $90 million. In 2008, contributions to EBITDA from this program should increase an additional $120 million to $130 million. Now let me remind you that…

Thanks Dave. Let's start by turning to page 8 in the Powerpoint presentation that's posted on our website. Net sales were approximately $1.8 billion, up 23% from last year's results on continued strong global demand for Acetyl Intermediates, positive currency impacts across the company, growth in Asia, and the additional sales from the APL business that we acquired in 2007. Operating profits increased to $324 million from a $140 million in the fourth quarter of last year. In our U.S. GAAP operating profit results, we had approximately $93 million of income and other charges and adjustments during the fourth quarter primarily one-time gains associated with the partial business insurance recovery, the sale of our Edmonton Canada facility and resolution of commercial dispute with the vendor. Net earnings were $214 million versus $77 million a year ago. Our adjusted earnings per share and operating EBITDA exclude the income from these one-time gains. Adjusted EPS was $0.93 a share, based upon 28% tax rate. Operating EBITDA was $349 million, up 30% from last year's results. Now let's take a look at the results of our businesses, starting with Advance Engineered Materials on page 9. Net sales were up 13% from last year's results as the business experienced strong volume growth of 8%. We expect this business to grow at two times GDP as a result of innovation and the commercialization of new products. Higher raw material and energy costs however, continue to pressure margins for this business. Operating EBITDA was $45 million, down from last year's $58 million, driven by the lower margins as well as lower earnings relating to our equity affiliates. Keep in mind that these businesses which include Ticona and their strategic affiliates price on the value and use of their products. And as a result do not pass…

Thank you Steven. If we could have some instructions, for our participants and then we can get started in our Q&A. Question And Answer

[Operator Instructions]. And your first question comes from the line of David Begleiter from Deutsche Bank.

Thank you, good morning.

Hi, Dan.

Good morning.

David can you describe the situation right now in China in terms of acetic acid supply, demand, pricing, weather issues? Thank you.

Dave, pricing in China today is modestly lower than it was 30 days ago, 60 days ago. But we're still in the 650 a ton range plus, minus. The weather has not had a material impact on our ability to get product out to our customers or to secure raw materials. We've got open water access and we're continuing to operate and run over there. So, that's where it is. As you know, Dave from our comments, we'd expect as the year goes on the pricing trends would tend to moderate over there as move back into ranges that would be more historic, and it moved towards that in the later half of the year.

And did on that given the decline in methanol, should your profitability at least they are saying that does not increase, even as prices come down?

Yes, there is going to be trends down on prices and then methanol prices are going to come down as well that's our forecast, our expectation. But remember Dave, across the company we're relatively in different volatility in methanol prices. One part of our business is benefited while the other one is disadvantaged with lower methanol prices. Certainly as we look at Ticona as I indicated, their margins are pressured by methanol and as methanol prices come down, you can expect to see an expansion there.

And just lastly on the Industrial Specialties side, is this level of income now sustainable for, in Q4 going forward?

Yes, I mean we're... I would say that we're at the early stages of our revitalization in Industrial Specialties. We did see two or three really good things towards the end of the quarter. We had very nice pricing in the marketplace, our mix changed towards a more advantageous, more value-added mix. And some of the restructuring costs associated... restructuring benefits associated with reducing our manufacturing footprint came in. So, our outlook is as we've indicated before that, this is a business that can do better, we're encouraged by what we saw in the fourth quarter.

Thank you very much.

Thanks David.

Thanks Dave.

Your next question comes from the line of Edlain Rodriguez from Goldman Sachs.

This is actually Joe Herrick with Gutterner Research. Couple of things for you guys, can you talk about your operational improvement initiatives and your plans revolving around and it need actually in Six Sigma and what benefits you expect to see this year?

Yes, we've... our program around our profit improvement program that we announced in 2006, has a number of elements associated with it, putting new manufacturing capacity in Asia, revitalization in some businesses, gaining synergies out of some of the acquisitions and so on. That entire program will benefit earnings this year in 120, 130 range. A big part of that... the improvement that we're going to see in the Industrial Specialties business is around the revitalization and a big part of that is restructuring our manufacturing footprint, our R&D, and our SG&A. So we haven't broken it out much more than that, we do have an ongoing program of Six Sigma that we introduced as a company in 2000, that program plus several other programs we target offsetting inflation in our numbers. We view inflation to be somewhere in the $75 million to $100 million range and over the course of the last seven or eight years, we've been successful in offsetting inflation in the numbers through real cost takeouts associated with Six Sigma and other programs.

What methods are you guys using in your plans to measure yourself. Are you looking at ORONA? Are you looking at OE? What's important to you guys to measure, and how are you working, measuring yourself up to your competitors?

We used a number of measurements... on an income statement, we'll look at EBITDA, as a percentage of sales, and EBITDA growth to measure ourselves against our competitors, and peers. On cash utilization, we have a high level metrics that we use around TSR associated with the output. Obviously, the bulk of programs, but in deployment of cash, and deployment of capital we'll use an ROI. We do on a lot of things look at a simple payback as an example, as we look at cash going into any type of restructuring program, or any type of investment for costs take out at manufacturing. We look at simple payback of 2 to 2.5 years on that and if we'll prioritize against those type of metrics. For growth, the ROI is after-tax adjusted is somewhere in the upper teens, lower 20% range. I'd highlight to you that Investor Day this last December, we talked about our investment in Nanjing China, and that's an investment that will generate $600 million to $800 million of revenue, and have a earnings flow in the 150 plus range, or so in it, and the total capital deployed in that activity is in the $300 million range. Certainly north of 20%, and the way we look at it. Thank you.

Regarding throughput, are there certain plants around the world that are more concerning to you going forward this year than others, and how do you plan to address those issues a little bit quickly [ph]?

No, no, I mean, we tend to look at our manufacturing footprint on an ongoing basis, good times or bad times, and we've been forthcoming in the type of areas that we are looking at reducing manufacturing footprint and expanding. Over the last seven years, we've essentially invested significantly in Asia to follow our customers, and we move back across North America and Europe on consolidated manufacturing in those locations. We are spending capital to go after some energy programs, and we've reduced the energy consumption by about 25%, since 2000, and we have plans to reduce an additional 25% from 2007 base year out for 2010. Thank you for your questions.

Your next comes from the line of Edlain Rodriguez from Goldman Sachs.

Thank you Dave. Quick question, when you are looking at Ticona, are you essentially at the mercy of raw material volatility, or can you add... can you sort adding some wiz bang [ph] in those products in order to add value for you to raise prices?

Edlain you articulated our strategy very clearly. Ticona is a very substantial investor in technology, and technology development. That technology is in three areas, one is a short term application just getting in, and getting short term applications with our customers. The second is becoming established on platforms, so we are working 2010-2011 platforms, and transportation is an example, and getting specked in as those specs come in the volume will pick up. And then longer term, we are investing in changing molecular structures, looking at different platforms that we can... molecular platforms that we can drive growth off of. So what we've done in Ticona, we'll continue to do in Ticona is to focus on bringing value to our customers, and solving solutions. We don't chase a lot of the genericized activities. The focus on growth is clearly associated with innovation in bringing these solutions to our customers.

Okay thank you. Another question on cash flow there. You've been generating very strong cash flow. You do believe that the stock is undervalued. Can you talk about the merits of a share buyback, or what can you do with that cash flow?

Yes, a great question. We look at cash flow and we believe it's the shareholders, cash, and our responsibility is to find great ways to deploy that capital. It increases value to the shareholders. 2007, I think was a good example of what we do with cash. We made an acquisition with some of the cash in APL. Very accretive acquisition, post synergies, it's probably going to be ForEx multiple on the acquisition. We also sold a business that was in our mind not part of our strategy going forward. We did a share buyback to deploy some of that cash back to the shareholders. We did a restructuring program around our balance sheet, it's been about $265 million of cash, and breakage cost in order to put ourselves in a better position with covenant light agreements, and some great financing taking us out through 2014. So, you know included in, and we continue to invest, our capital spending is up about $50 million from prior year. As we look at investing, and growing regions of the world, such as China. So then we look at it on an ongoing basis. We like acquisitions. We like being focused on growing, and following our strategy. We have looked at share buyback in the past, and I think as we discussed with the board different options, every option is on the table.

Okay thank you.

Thanks Edlain.

Your next question comes from the line of Kevin McCarthy from Banc of America Securities.

Yes. Good morning.

Hi Kevin.

Dave if I look at Consumer Specialties your volumes have been under some pressure there for several quarters now. You referenced the shift of flake production to your Chinese ventures. Have you seen any market share shifts in that business as well and can you update us on the integration of APL, is that process close to complete now?

Yes. We have shifted volume as part of our revitalization program that was announced at IPO three years ago. We've shut down our Edmonton, Canada manufacturing facility that used to export an awful lot of flake to China and we've increased the flake production in the Chinese joint venture to offset that. And that's why our volumes are down. Our earnings though were up as a revitalization program goes on. We have not seen substantial shift in share. It's a relatively stable market and there is not a lot performance big movements in share out there. APL is a great add for us. We've been just absolutely delighted with the type of activities that we've been able to put into APL. We bumped volumes little bit. We've been able to balance our global supply chain and we have some good savings on not only SG&A but also distribution cost. We have a little bit more synergies in 2008 in APL, but it is more associated with the annualized impact of activities that were completed last year. We are essentially down from an activity base.

Okay, great. And then shifting over to acetyl, if I look at your volume growth there of 12%, what kind of a plant loading rate is baked into that for Nanjing and perhaps you could elaborate more broadly on your acetic acid operating rate, company wide and industry wide for that matter.

Yes, let's talk about fourth quarter first. Fourth quarter as you are aware was a pressured quarter in the market. Demand was very high so all of our facilities in the fourth quarter were operating in full rates. Part of that was growth in the market, part of it frankly was as a catch up as customers and value chains added back inventory levels caused by our outage and other outages in the market in the middle of the year. As we look at the first quarter operating rates continue to be in a very good range. I would probably say that on a... they are probably between 90% to 95% operating rates now. There have been some facilities in China; some of you who follow us closely, recognize that some of the Chinese facilities on stream reliability is lower. Some of the facilities have had trouble securing natural gas and they have been out or operating at 40% or 50% rates in Asia and China. But, overall we are operating somewhere in the 95 plus minus percent range.

Okay. And then a final question for Steven if I may on the special items. If I look at Edmonton at $34 million, insurance recoveries of $40 million and another $31 million from the vendors dispute resolution. It's about a $105 million can you comment on how much of that is cash and how much was received in 4Q whether or not there is any tail looking into 2008?

Sure, actually all that was cash except for about $7 million and related to our insurance recoveries that we have already received in January this year. So, nearly all cash in Q4 and the rest received in 2008. We made great progress on this... took a moment about the Clear Lake insurance recovery. As we talked over the last couple of quarters these tend to be long run out processes that can take six to eight quarters, and I'm very pleased with the progress we've made to-date, collecting $40 million in cash as a progress payment and there will be still claims outstanding. We're going to continue to work those and expect to see cash in the future on what they do as those progress.

Thanks very much.

Kevin, keep in mind that any potential recoveries on the Clear Lake insurance would not be part of our guidance. So it be additive to that. We would adjust it that like we did in the fourth quarter. So we will be very clear and transparent when we do receive those and just to reiterate it's not in any of our guidance that we have for 2008.

Understood thanks.

Yes.

Your next question comes from the line of Sergey Vasnetsov from Lehman Brothers.

Good morning.

Good morning.

David you mentioned that you have several options of cash deployment on table but you also have lot of cash in the table. In rough terms maybe $1 billion in 2008 not that you need to spend it all in one year. But I just wanted you to maybe focus a bit more on how you think about relative priorities, all different options, acquisitions, dividend increase, share buyback and maybe debt repayments anything else.

Yes, thanks Sergey. I think our view of cash is we wanted to put it to use in a way that as I said before we'll generate higher return to shareholders. Our focus on acquisitions tends to be strategic centered the fair way, bolt-on acquisitions similar to APL or Acetex that we did in 2006. So I would say between investing in our ongoing businesses and following our strategy and if we can plan a good acquisition those would probably receive the highest focus in our pyramid of uses of cash. The lowest on the pyramid would be debt repayment and with the type of financing that we have today and with our comfort in ongoing cash generation through the future, and the maturity that we have on the debt, the lowest priority would be debt repayment. And then somewhere in the middle would be, dividend, share buyback, and again Sergey we do have a nice cash position today. We have a forward leaning strategy associated with acquisitions, and investment in our businesses in Asia, and the growing region of the world. And so we will continue to look at things, and have discussions with the board, as we go forward as to use of cash, excess cash beyond acquisitions.

Okay and as a follow-up, you said the number of joint ventures and some in Asia in particular. How would you... have any chance that you might be able to buy out your partner there?

It's a deep desire of ours to buy these ventures out. The ventures we have put in place, particularly the ones in Ticona were put in place 40 years ago, in some cases close to 50 years ago, when the world was entirely different. You needed a strategic partner in order to access that part of the world, and the world has changed dramatically. Customers are looking for one global experience, one solution, not a bifurcated solution. And however the agreements are structured in a way as we have said in prior discussions that, don't give us unilateral right to buy a partner out and they are great ventures, who are generating great earnings, and great cash, and the partners at this point in time seem to not be motivated to sell. If they were, we are there.

Thank you.

Thanks Sergey.

And your next question comes from the line of Frank Mitsch from BB&T Capital Markets. Frank Mitsch - BB&T Capital Markets: Good morning gentlemen.

Hi Frank. Frank Mitsch - BB&T Capital Markets: Hey if I could just quickly follow-up on the insurance recovery, you said that you got about net 33 in the fourth quarter, and there should be some more in 2008 order of magnitude should we be looking at a similar amount that sort of order of magnitude in 2008?

No at this time, the only thing I'll talk about in 2008, as we receive $7 million additional cash, so in the P&L for GAAP say $40 million in the fourth quarter, 33 of cash, and another 7 of cash in the first quarter. Note the complexity of these claims its still too early to call, the impact in terms of cash, and P&L for 2008. And as Mark mentioned earlier, its not in our guidance so, as we progress through the year, we get a better sense of how this is evolving we'll update you.

Frank I will underscore what we said at Investor Day in prior times as well that when we look at our performance in 2007, in spite of the outage that we have, we think that the performance of the business came in about where it would have been, if we didn't have the outage. The reason is that we had not only our plant that went out, but we also had a number of competitor's plants go out in this space, both VAM plants, as well as acid plants, and it touched... frankly all three regions of the world. And so from our customers' perspective, unfortunately it was a cascade of unfortunate situations, but the net impact for us with all these things thrown together was a year that came out about where we thought it was going to be, little bit higher on pricing, a little bit lower on volume. Frank Mitsch - BB&T Capital Markets: But it terms of earnings, much better than your initial guidance for '07?

Yes, 2007 was a good year for us. We continued to make progress in a lot of our businesses. I think from our perspective the progress that was made in growth in Ticona was ahead of where we thought it was going to be. Acetyl Intermediates had some good growth, the Nanjing facility as we highlighted came up earlier than we had anticipated. It came up around stronger than we thought it might have been. So, 2007 was a great year for us absolutely. APL acquisition and some of the synergies there came in faster. Frank Mitsch - BB&T Capital Markets: That kind of bakes a question in mid-December when you had your Investor Day, you talked about your expectation for the fourth quarter and obviously you came in nicely higher than that. Do I have to believe you set the higher price in demand, so that would imply that December ended on kind of an up note, or a significant up note. Are those sorts of trends continuing here in the first quarter?

As we appreciate you are asking a question Frank that most visibility that we have in our business is with our Ticona business. We have an order book that builds out, and we have some transparency. I'd say 45 days into the future. As we look at the Ticona order book out in to the February to March timeframe, we see growth. We see demand remaining good in all regions. We see some segments that have been sluggish, remaining sluggish, but on a year-over-year basis, we see a positive environment. I wouldn't call it robust, or be highly energized about it, but it is a growth environment globally in our businesses. Frank Mitsch - BB&T Capital Markets: Dave, just a quick follow up in totality, you're describing it as in upbeat terms, but not quite swinging from the chandeliers, other regions of the world where you would be "swinging from the chandeliers?

The Asia region, Frank, continues to be very strong. We continue to be impressed with two things, the growth in internal demand in China, and then how rapidly that growth is shifting towards latest greatest technology. Just to give you an example, transportation automotive. China today is the third largest producer of cars in the world. By 2012, it will be the largest producer of that. They tended to be basic transportation a year or two ago. Now they are putting additional creature comforts on the car safety systems, believe it or not, emission standards, fuel economy standards, GPS systems on some of the higher upgraded models. They are very rapidly moving towards a western type of vehicle. What that means for us is additional pounds of Ticona type product on an automobile. So I would say that Asia, China in particular continues to register good growth and probably somewhat ahead of what we thought it might be. Frank Mitsch - BB&T Capital Markets: Terrific, thank you.

Thanks Frank.

And your next question comes from the line of Gregg Goodnight from UBS.

Good morning all, hi, you mentioned the cost pressure that Ticona saw qualitatively, how much of that cost pressures due to high international methanol prices and if methanol prices subside would the cost pressure subside?

It's... methanol prices as you know Greg, it just shot up and our ability to... frankly our strategy is not to pass those along customers because we sell on value and we have great margins per pound on these types of products, but order of magnitude it was about $30 million that we saw it was some pressure on the margins. And yes, you are absolutely right, it's the model that as these commodity prices decline, methanol is the biggest one but it also consumes ethylene and some other propylene derivatives. We would expect that you would have acceleration in margins.

Okay, question on this Southwest Research Agreement, what technologies are they into? Do they have methanol carbonylation technology? Or is it more downstream polymer? Is it even more even downstream from that application related?

There is... it's a... this is all public information, but let me summarize it for you. Southwest Research Institute has technology associated with the CD gas oil production, some in downstream products, methanol carbonylation have some technology around that. So with this transaction, we were fortunate to acquire license rights exclusively for that technology plus they are very creative group and we are excited to get involved and have them work with us on expanding and extending our advantage in this change.

I see. Historically have they had... or have they given our sole methanol carbonylation licensing?

Yes, there is the few plants in Asia that are operating and others that had been licensed, they tend to be smallest plants but yes, there was a plants that they had licensed.

Good. Just a clarification for my purposes. You mentioned the free cash flow of $500 million to $550 million expected in '08. And then you also mentioned the cost to back cash of... I thought I heard $50 million to $100 million this year, is that reimbursable in this year or is any of that in the 5 to 550?

Gregg, let me give you a little context on then will Steve will answer this specific question. When we established the settlement with Fraport to move our facility and sell our facility, we essentially brokered an arrangement that was cost neutral. Now what does that mean? Well it means not only capital spending, but also any cost associated with prequalification with customers, anything associated with any labor that needs to be done and it was a fixed amount. The agreement, we've also indicated provides incentives to be totally spent in Germany, or disincentives if it's not totally spent and not spent in Germany. And then Steve do you want to walk through kind of how the cash comes in.

Yes, as we talked about last year, we expect to receive €670 million in reimbursement. But that's going to be over an extended period of time between now and 2011. And we are beginning the preconstruction process, and our capital expenditures will begin to occur overtime and because of the lumpiness of the reimbursement versus our spending, we wanted to provide transparency to the airport relocation. So you'll see in all of our reports beginning this year and going forward will highlight the net impact separately from our normal capital expenditures or the relocation. But I did mention in 2008, 50 million to 100 million is in debt over the reimbursement and we will receive about €200 million euros in reimbursement 2008.

And Gregg, just to put a bow on it and underscore what I said in the opening remarks, that facility will be 40% larger than our existing facility to support the growth in Europe, and it will employ the latest greatest technology not 30, 40 year old technology, and yield lower operating cost.

Okay, when you said €40 million to €50 million net, that's net positive or net negative of reimbursements?

Negative this year. It will be the outflow $50 million to $100 million.

Okay and that is not in your free cash flow of 500 to 550?

That's right.

Okay, thanks.

Thanks Gregg.

Your next question comes from the line of Charles Neivert from Morgan Stanley.

Good morning guys.

Good morning.

Good morning.

Got a couple of quick questions. The progress on the China facility, is that sort of in line with what you guys have been talking about? Is it moving a little long or little bit quicker and given how quickly the acetic acid came up. Are you expecting sort of maybe something close to similar performance in terms of bringing up these facilities at this point, having learnt from the first pass through?

We're right on track, I'd say that some units are modestly ahead of other units may lag a month or two. But as we stand here today we have an operational acetic acid unit. We have an operational emulsion unit and our long fiber units, Celstran unit became operational this month. We have three other units that are currently under construction, we anticipate startup through this year and into next year that's a GUR unit and an hydride unit and also a VAM unit. And then we announced in the fourth quarter that we are going to put in place a 7th unit which is a compounding unit and that should be operational in 2009. The learnings from acetic acid startup I think are several fold. First, we were frankly delighted with the quality of construction at the location. Second, we were diluted with the employees and the skills and capabilities that they brought to the job. And third we are delighted with the raw material supplier. The CO vendor was... in our mind one of the question marks that we had going into among others. But that question mark was eliminated and that's what gave us confidence to go forward and commit to a doubling of the CO supply in the 2009, 2010 timeframe.

And one other... you talked about obviously the Chinese car production coming up rather rapidly and moving more toward convenience as you see typically in the U.S. and Europe are more typically here. How is your capture rate on putting Ticona products in those cars and versus what you got in some of the others here? I mean not in tonnage, but just sort of X tons... X pounds are available, how much are you guys taking?

Yes, I'll take it into two main areas. There are a lot of western transplants, either European or North American transplants that are taking their production over there and manufacturing there, some for local consumption but as much as anything to capture the labor arbitrage and move it to the other parts of the world or finished products to other parts of the world. In that area it is essentially 100% capture rate either ourselves or through the affiliated companies, we are capturing essentially a 100% of that. With the innovation by Chinese manufacturers, I say our capture rate is pretty high, and I am sorry Charles I don't have the details on that. But I will tell you that we are seeing at an incredible dynamic where the Asian manufacturers want the latest and greatest technology and they are willing to pay for it. And so, when we bring in our learning's over the last 20, 30, 40 years in Ticona in a particular application such as the fuel injector system in automotive or a safety device in transportation. There is very rapid acceptance, there is very rapid prototyping and putting on to a new vehicle or a new appliance. And they pay for the innovation that we bring to it. We are not chasing the low end business over there, its high end.

And just as a follow on, I mean if you look at let's say, a U.S. or a European company, how... versus sort as to China, I mean how quickly did they bring prototype to market versus here, they talk about, you want to redesign a particular car its X number of years. How quickly can they bring in new parts and things like that into the cars and incorporate some of your products?

It's markedly faster in China than it is here. Again we saw one example, recently that took... I think three years of prototyping and development in... I think this is a European... within the European context and it was done in nine months in China.

Okay. That's it. Thank you very much.

Thanks Charles.

Thanks Charles.

Your next question is from the line of Andrew O'Connor from Millennium Partners.

Hi Andrew.

Hi David, Steve, Mark congratulations on the quarter.

Thanks Andrew.

Related to the industry production outages in Acetyl Intermediates, how long do you guys expect current outages to linger? Thanks so much.

Yes the overall view that we have has changed in the last six months. We had assumed that there was an on-stream reliability for the industry in the 90% to 92% range. We found though that the new facilities coming in China bring the overall industry average down to 87%, 88% on-stream reliability. The Chinese facilities and the raw materials suppliers that tie into them have not been able to have as much success in keeping their plants running as western manufacturers have, certainly as we have. And as a consequence of that it's tough to predict exactly what units are going to come up and when they are going to come up or down. But we do expect supply demand through 2009 and 2010... excuse me through 2010 to be very robust and stay in the 90 plus percent range. It could happen in any given year.

Got it, Thank you Dave, again great quarter.

Thank you Andrew.

We have time for one last question.

Your last question is from the line of William Matthew from Canyon Capital.

Hey guys kind of following-up on that previous question, you... the current spot prices for acetic acid are in Asia. I think you mentioned 650 per ton?

Yes, it's in that range.

Okay. What is your guidance based on a per ton basis. What kind of per ton number are you factoring in?

We judge that, though we judged at our... well let me back into it. The pricing in China now is set by some supply demand, but more than anything, that the marginal cost of the high cost producers. And that's the ethanol, and the ethylene guys, principally the ethanol guys. And so based on the reports we see out there, we believe the pricing for these high cost guys are going to trend down. Ethanol prices are going to trend down, and so through the year we have our prices trending down associated with that. And I would also say that into your pricing, we have it somewhere $550 and $600 a ton.

Okay so $550 to $600, I guess it's just hard for me to reconcile, a trending down in prices, but your operating rates are remaining the same. So, if you are saying that your operating rates remain tight for 2010, I just... conceptually it's hard for me to understand why prices would trend down and that means that your forward guidance is too conservative?

Are you accusing me of being cautious?

Bill, here's the logic in it. As you know in the acetyl acetic acid in particular, there is a very, very steep cost curve, and the pricing is established by the marginal cost of the high cost producers. In many cases, we judge that the market is either like that today, or moving into that situation over the next few weeks. And the marginal cost of the high cost producers according to published reports are going to be trending down into the second half of the year and so those prices trend down, they are ones who set the marginal price and we think that prices will trend down as well.

Okay and then the amount of affiliate earnings that are not captured in net income or the unconsolidated EBITDA, what is that for '07?

For '07, it was $93 million for the full year.

93.

If you want some detail, and if you look at our earnings release on table 8, you can see by quarter and by year at the bottom of the table, it was $93 million and there's only about $100 million of net debt associated with these affiliates on a proportional basis.

Okay. And so if we wanted to get a rough estimate for the evaluation of that using some kind of current EBITDA multiple say six times that number of times, an EBITDA multiple is kind of what's not captured in your share price?

Mathematically, you are correct but I think you would look at higher multiple, because most of the earnings in these businesses are in Ticona, which have higher growth rate. So we would expect to see a multiple on 8, branch for these new businesses.

Got it great, okay.

Thanks Bill. Thank you everyone.

Thank you for your participation in today's conference. This concludes the presentation. You may now disconnect, have a wonderful day.